Showing results (331-340 of 345) with videos related to

Sort By:
Pageof 35
The Lancet. Microbe|November 4, 2022
Genetic and phenotypic stability of poliovirus shed from infants who received novel type 2 or Sabin type 2 oral poliovirus vaccines in Panama: an analysis of two clinical trialsRahnuma Wahid, Laina D Mercer, Tirza De Leon, et al.
The Journal of Infectious Diseases|May 29, 2024
Nasal and Pharyngeal Mucosal Immunity to Poliovirus in Children Following Routine Immunization With Inactivated Polio Vaccine in the United StatesAudrey Godin, Ruth I Connor, Hanna N Degefu, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|September 28, 2010
Proton radiography of a shock-compressed targetA Ravasio, L Romagnani, S Le Pape, et al.
The Lancet. Global Health|July 2, 2016
Safety and immunogenicity of inactivated poliovirus vaccine when given with measles-rubella combined vaccine and yellow fever vaccine and when given via different administration routes: a phase 4, randomised, non-inferiority trial in The GambiaEd Clarke, Yauba Saidu, Jane U Adetifa, et al.
Science (New York, N.Y.)|March 21, 2020
Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccineG R Macklin, K M O'Reilly, N C Grassly, et al.
Lancet (London, England)|May 24, 2016
Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trialEdwin J Asturias, Ananda S Bandyopadhyay, Steve Self, et al.
Physical Review Letters|September 28, 2010
Fast advection of magnetic fields by hot electronsL Willingale, A G R Thomas, P M Nilson, et al.
The Journal of Infectious Diseases|October 5, 2021
Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical TrialsChristopher Gast, Ananda S Bandyopadhyay, Xavier Sáez-Llorens, et al.
NPJ Vaccines|February 12, 2022
Evaluating stability of attenuated Sabin and two novel type 2 oral poliovirus vaccines in childrenRahnuma Wahid, Laina Mercer, Chris Gast, et al.
Lancet (London, England)|December 14, 2020
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trialsIlse De Coster, Isabel Leroux-Roels, Ananda S Bandyopadhyay, et al.
Pageof 35